Fecal elastase-1 – a biomarker for pancreatic exocrine insufficiency (EPI) continues to gain traction as an ideal biomarker for assessing EPI. This presentation will include a review of the physiology and function of the pancreas, epidemiology and prevalence of disease, current clinical guidelines along with new and existing testing options for pancreatic insufficiency.
WAVE Newsletter Promotion8%
Trending Newsletter Promotion2%
Medical Laboratory Technician19%
Clinical Laboratory Scientist12%
Medical Device Company3%
Life Science Company2%